News | Neurological conditions

Feature

Demystifying medical cannabis: five years on from legalisation

Although medical cannabis was legalised in the UK in 2018, a lack of evidence for unlicensed products has meant NHS prescribing is still extremely limited while the private market continues to grow.…

Published: 28 September 2023

News

Second ADHD medication shortage leaves patients in ‘very difficult position’, pharmacists warn

A medicine supply notification warned that atomoxetine 40mg and 60mg capsules will be out of stock until September 2023…

Published: 3 August 2023

Feature

Special report: charting the rise in ADHD prescribing

Despite a rise in people receiving treatment for attention deficit hyperactivity disorder in England, particularly adults, data show the condition continues to be significantly underdiagnosed.…

Published: 27 July 2023

Opinion

Reducing overprescribing and improving the health of patients with learning disabilities and autism

Rizwana Dudhia shares how a project she initiated to prevent the prescribing of inappropriate medication improved the quality of life for patients with learning disabilities and autism.…

Published: 24 July 2023

News

Patient safety commissioner begins work on compensating families affected by sodium valproate

Exclusive: The patient safety commissioner will publish a report on redress options for people affected by sodium valproate and pelvic mesh.…

Published: 20 July 2023

Feature

Would UK approval of lecanemab be a game changer for people with Alzheimer’s disease?

Experts are divided over whether lecanemab is a cost-effective intervention for Alzheimer’s disease, raising concerns that the NHS is not ready for it.…

Published: 20 July 2023

Opinion

Women with epilepsy need choice, not diktats, when it comes to sodium valproate

The NHS needs to fully audit its approach to valproate and should be supporting women to make informed choices regarding their treatment.…

Published: 28 June 2023

News

ADHD and central nervous system stimulant prescribing nearly doubles in adults in three years

Exclusive: Prescribing of central nervous system stimulants and medicines for attention-deficit hyperactivity disorder in adults in England increased by 91% between January 2020 and January 2023.…

Published: 27 June 2023

News

Anti-epileptic shortages are ‘concerning’, patient support organisations say

The Department of Health and Social Care has confirmed that packs of Trileptal 300mg and 600mg tablets will be unavailable from late June 2023 until mid-July 2023.…

Published: 21 June 2023

News

Medicated wafer to be approved for the treatment of frequent migraines on the NHS

Rimegepant will be available on the NHS for patients who have tried at least 3 other preventative therapies, and have at least 4 and fewer than 15 migraine attacks per month.…

Published: 1 June 2023